Tag: ankylosing spondylitis

Pfizer’s tofacitinib succeeds in phase 3 ankylosing spondylitis trial

pharmanewsdaily- November 8, 2020 0

Pfizer said that a phase 3 clinical trial of XELJANZ (tofacitinib) in adults with active ankylosing spondylitis (AS) has met its primary endpoint. The late-stage ... Read More

Amazing Arthritis Prevention Tips & Natural Remedies for Arthritis Revealed!

pharmanewsdaily- March 30, 2018 0

Know about Arthritis – the common bone and joint problem. Find out the different types of Arthritis, Arthritis treatment and the Arthritis natural Remedies. Arthritis ... Read More